Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906)
Karine Scherzinger-Laude,1 Carina Schönherr,2,3 Felicitas Lewrick,3 Regine Süss,3 Giancarlo Francese,2,* Jochen Rössler1,* 1Clinic IV, Pediatric Hematology and Oncology, Center of Pediatrics and Adolescent Medicine, University Medical Hospital Freiburg, Germany; 2Departmen...
Guardado en:
Autores principales: | Scherzinger-Laude K, Schönherr C, Lewrick F, Süss R, Francese G, Rössler J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1a61f603b244a749d3eb77293d311b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumor targeting using liposomal antineoplastic drugs
por: Jörg Huwyler, et al.
Publicado: (2008) -
Bilateral horizontal Vogt’s striae in keratoconus
por: Inci Ulu Güngör, et al.
Publicado: (2008) -
Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
por: Özcan İ, et al.
Publicado: (2013) -
Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties
por: Gradauer K, et al.
Publicado: (2012) -
Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO
por: Ebert S, et al.
Publicado: (2012)